Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Clinicopathological significance of S100 protein expression in cholangiocarcinoma.

Sato Y, Harada K, Sasaki M, Nakanuma Y.

J Gastroenterol Hepatol. 2013 Aug;28(8):1422-9. doi: 10.1111/jgh.12247.

PMID:
23621473
2.

Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.

Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, Shirabe K, Maehara Y, Oda Y.

Am J Surg Pathol. 2011 Apr;35(4):590-8. doi: 10.1097/PAS.0b013e31820ffdf1.

PMID:
21412073
3.

Heat shock proteins 27 and 70 are potential biliary markers for the detection of cholangiocarcinoma.

Sato Y, Harada K, Sasaki M, Yasaka T, Nakanuma Y.

Am J Pathol. 2012 Jan;180(1):123-30. doi: 10.1016/j.ajpath.2011.09.010. Epub 2011 Nov 1.

PMID:
22051775
4.

S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.

Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM.

Histopathology. 2012 Dec;61(6):1106-16. doi: 10.1111/j.1365-2559.2012.04316.x. Epub 2012 Aug 8.

PMID:
22882148
5.

Autophagy may occur at an early stage of cholangiocarcinogenesis via biliary intraepithelial neoplasia.

Sasaki M, Nitta T, Sato Y, Nakanuma Y.

Hum Pathol. 2015 Feb;46(2):202-9. doi: 10.1016/j.humpath.2014.09.016. Epub 2014 Oct 23.

PMID:
25466963
6.

Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.

Hamada S, Satoh K, Hirota M, Kanno A, Ishida K, Umino J, Ito H, Kikuta K, Kume K, Masamune A, Katayose Y, Unno M, Shimosegawa T.

Cancer Sci. 2011 Jan;102(1):150-6. doi: 10.1111/j.1349-7006.2010.01757.x. Epub 2010 Oct 13.

7.

Expression of cell cycle-related molecules in biliary premalignant lesions: biliary intraepithelial neoplasia and biliary intraductal papillary neoplasm.

Nakanishi Y, Zen Y, Kondo S, Itoh T, Itatsu K, Nakanuma Y.

Hum Pathol. 2008 Aug;39(8):1153-61. doi: 10.1016/j.humpath.2007.11.018. Epub 2008 May 20.

PMID:
18495210
8.

Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.

Wu Z, Boonmars T, Nagano I, Boonjaraspinyo S, Srinontong P, Ratasuwan P, Narong K, Nielsen PS, Maekawa Y.

Int J Cancer. 2016 Jan 15;138(2):396-408. doi: 10.1002/ijc.29721. Epub 2015 Aug 27.

PMID:
26312563
9.

Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis.

Alvaro D, Macarri G, Mancino MG, Marzioni M, Bragazzi M, Onori P, Corradini SG, Invernizzi P, Franchitto A, Attili AF, Gaudio E, Benedetti A.

Ann Intern Med. 2007 Oct 2;147(7):451-9. Erratum in: Ann Intern Med. 2007 Nov 6;147(9):676.

PMID:
17909206
10.

Expression of S100 protein family members in normal skin and sweat gland tumors.

Zhu L, Okano S, Takahara M, Chiba T, Tu Y, Oda Y, Furue M.

J Dermatol Sci. 2013 Jun;70(3):211-9. doi: 10.1016/j.jdermsci.2013.03.002. Epub 2013 Mar 16.

PMID:
23623205
11.

The value of biliary fibronectin for diagnosis of cholangiocarcinoma.

Chen CY, Lin XZ, Tsao HC, Shiesh SC.

Hepatogastroenterology. 2003 Jul-Aug;50(52):924-7.

PMID:
12845951
12.

The expression of S100A4 protein in human intrahepatic cholangiocarcinoma: clinicopathologic significance and prognostic value.

Tian X, Wang Q, Li Y, Hu J, Wu L, Ding Q, Zhang C.

Pathol Oncol Res. 2015 Jan;21(1):195-201. doi: 10.1007/s12253-014-9806-6. Epub 2014 Jul 2.

PMID:
24985031
14.

Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.

Han Y, Zhang W, Liu Y.

World J Surg. 2013 Oct;37(10):2419-27. doi: 10.1007/s00268-013-2132-4.

PMID:
23793608
15.

Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.

Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.

Hum Pathol. 2008 May;39(5):710-9. doi: 10.1016/j.humpath.2007.09.016. Epub 2008 Mar 10.

PMID:
18329694
16.

Extrahepatic bile duct carcinoma with extensive intraepithelial spread: a clinicopathological study of 21 cases.

Nakanishi Y, Zen Y, Kawakami H, Kubota K, Itoh T, Hirano S, Tanaka E, Nakanuma Y, Kondo S.

Mod Pathol. 2008 Jul;21(7):807-16. doi: 10.1038/modpathol.2008.65. Epub 2008 Apr 18.

17.

Clinicopathological review of 61 patients with early bile duct cancer.

Cha JM, Kim MH, Lee SK, Seo DW, Lee SS, Lee JH, Lee SG, Jang SJ.

Clin Oncol (R Coll Radiol). 2006 Nov;18(9):669-77.

PMID:
17100152
18.

Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N.

World J Surg. 2007 Sep;31(9):1788-96. Epub 2007 Jul 25.

PMID:
17647056
19.

Histological characteristics of biliary intraepithelial neoplasia-3 and intraepithelial spread of cholangiocarcinoma.

Sato Y, Harada K, Sasaki M, Nakanuma Y.

Virchows Arch. 2013 Apr;462(4):421-7. doi: 10.1007/s00428-013-1384-6. Epub 2013 Feb 28.

PMID:
23446751
20.

Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma.

Matsuda A, Kuno A, Kawamoto T, Matsuzaki H, Irimura T, Ikehara Y, Zen Y, Nakanuma Y, Yamamoto M, Ohkohchi N, Shoda J, Hirabayashi J, Narimatsu H.

Hepatology. 2010 Jul;52(1):174-82. doi: 10.1002/hep.23654.

PMID:
20578261
Items per page

Supplemental Content

Write to the Help Desk